Bottom line
FBTTX vs BBH: the short answer
FBTTX (Fidelity Advisor Biotechnology Fund) and BBH (VanEck Biotech ETF) are both mutual funds.
But FBTTX is far broader, holding 129 positions to 25 for BBH, so beyond the top names it adds exposure BBH doesn't have.
BBH is cheaper at 0.35% vs 1.19% — a difference of $84 a year per $10,000 invested.
Over five years, FBTTX returned +6.6% a year vs +2.7% for BBH (reporting dates differ).
Updated Nov 19, 2026
FBTTX vs BBH side by side
| FBTTX | BBH | |
|---|---|---|
| Type | Mutual fund | ETF |
| Fund family | Fidelity | VanEck |
| Category | Technology Sector | Technology Sector |
| Expense ratio | 1.19% | 0.35% |
| Annual cost per $10k | $119 | $35 |
| 10-yr cost on $10k (prospectus) | $1,743 | $443 |
| Max front load | — | None |
| 12b-1 fee | 0.5% | — |
| 1-yr return | +34.4% | +21.2% |
| 5-yr return (annualized) | +6.6% | +2.7% |
| 10-yr return (annualized) | +7.6% | +4.5% |
| Best quarter | +30.3% | +27.6% |
| Worst quarter | −27.8% | −18.2% |
| Net assets (fund) | $2.2B | $395.6M |
| Number of holdings | 129 | 25 |
| Portfolio turnover | 54% | 19% |
| Returns as of | Sep 30, 2026 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
10 of FBTTX's top 25 holdings also appear in BBH's top 25.
| Holding | FBTTX | BBH |
|---|---|---|
| Gilead Sciences Inc | 5.70% | 12.79% |
| Alnylam Pharmaceuticals Inc | 3.62% | 3.83% |
| Insmed Inc | 3.05% | 2.67% |
| Revolution Medicines Inc | 3.00% | 5.27% |
| Argenx Se | 3.00% | 4.97% |
| Biogen Inc | 2.71% | 3.63% |
| Amgen Inc | 2.37% | 15.25% |
| Moderna Inc | 1.60% | 3.36% |
| Natera Inc | 1.43% | 4.92% |
| Vertex Pharmaceuticals Inc | 1.39% | 9.10% |
Source: SEC Form N-PORT
FBTTX top 10
- Abbvie Inc — 14.71%
- Gilead Sciences Inc — 5.70%
- Spyre Therapeutics Inc — 3.83%
- Alnylam Pharmaceuticals Inc — 3.62%
- Dianthus Therapeutics Inc — 3.55%
- Cogent Biosciences Inc — 3.25%
- Oruka Therapeutics Inc — 3.24%
- Insmed Inc — 3.05%
- Revolution Medicines Inc — 3.00%
- Argenx Se — 3.00%
BBH top 10
- Amgen Inc — 15.25%
- Gilead Sciences Inc — 12.79%
- Vertex Pharmaceuticals Inc — 9.10%
- Regeneron Pharmaceuticals Inc — 6.21%
- Revolution Medicines Inc — 5.27%
- Argenx SE — 4.97%
- Natera Inc — 4.92%
- IQVIA Holdings Inc — 4.31%
- Alnylam Pharmaceuticals Inc — 3.83%
- Biogen Inc — 3.63%
FAQ
What is the difference between FBTTX and BBH?
Which is cheaper, FBTTX or BBH?
Should I own both FBTTX and BBH?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.